John Quackenbush

Add links
Source: Wikipedia, the free encyclopedia.
For the politician, see John A. Quackenbush.
John Quackenbush
Born
Institute for Molecular Bioscience, (University of Queensland)
ThesisGauge field theory in two space-time dimensions: Anomalies and applications to string models (1990)
Doctoral advisorTerry Tomboulis
Websitewww.dfhcc.harvard.edu/insider/member-detail/member/john-quackenbush-phd/

John Quackenbush is an American

Harvard School of Public Health.[5][6][7][8][9]

Education and early life

A native of

Wilkes Barre, graduating in 1979, after which he attended the California Institute of Technology, where he earned a bachelor's degree in physics. He went on to earn a doctorate in theoretical physics from the University of California, Los Angeles in 1990.[10][11]

Career and research

After working two years as a

human chromosome 11, followed by another two years at Stanford University developing new laboratory and computational strategies for sequencing the human genome.[10]

In 1997, Quackenbush joined the faculty of

microarray analysis. Using a combination of laboratory and computational approaches, Quackenbush and his group developed analytical methods based on the integration of data
across domains to derive biological meaning from high-dimensional data.

In 2005, Quackenbush was appointed to his current positions at the

Harvard School of Public Health.[10] Four years later, he launched the DFCI's Center for Cancer Computational Biology,[12] which he directs and which provides broad-based bioinformatics and computational biology support to the research community through a collaborative consulting model, and which also performs and analyzes large-scale second-generation DNA sequencing.[13]

Quackenbush's current research focuses on the analysis of human cancer using systems biology-based approaches to understanding and modeling the biological networks that underlie disease. This has led him and his colleagues to make fundamental discoveries about the role that variation in gene expression plays in defining biological phenotypes.

In 2010, Quackenbush and his colleagues at CCCB, together with investigators at

pulmonary disease
and thus develop more effective, personalized treatments.

In 2011, Quackenbush published The Human Genome: Book of Essential Knowledge (Imagine Publishing, U.S.), which outlines the history, science, and implications of the Human Genome Project. He was also awarded a four-million-dollar fellowship bestowed by Australia's National Health and Medical Research Council to study chemotherapy resistant ovarian cancers in collaboration with colleagues at the University of Queensland's Institute for Molecular Bioscience.[16]

Quackenbush currently serves on the editorial boards of five major journals and is editor-in-chief at Genomics. He has served on several committees at the

Institute of Medicine, including the Committee on Validation of Toxicogenomic Technologies: A Focus on Chemical Classification Strategies,[17]
National Institute for Health's Roadmap Epigenomics Project. Quackenbush is also a member of the scientific advisory boards of a number of biotech and precision medicine companies, including Caris Life Sciences, SynapDx, Perthera, and NABsys.[citation needed
]

In 2011, Quackenbush, along with partner Mick Correll, founded Genospace, a software company focused on developing tools to enable precision genomic medicine.[10] As of 2014, Quackenbush was the chief executive officer of Genospace.[10] In the summer of 2013, Quackenbush was honored as a White House Open Science Champion of Change.[21]

In January, 2017, Genospace was acquired by Hospital Corporation of America (HCA) and merged with HCA's Sarah Cannon cancer institute as a wholly owned subsidiary.

Publications

Scholia has an author profile for John Quackenbush.
Books
  • Author, The Human Genome: Book of Essential Knowledge (Imagine Publishing, U.S., 2011)
  • Contributor, Bioinformatics: A Practical Guide to the Analysis of Genes and Proteins (Wiley Interscience, 2004)
  • Coauthor, Microarray Gene Expression Data Analysis: A Beginner's Guide (Wiley-Blackwell, 2003)

References

  1. ^ John Quackenbush publications indexed by Google Scholar
  2. ^ John Quackenbush's publications indexed by the Scopus bibliographic database. (subscription required)
  3. ^ "Researcher Profile, John Quackenbush, PhD". Dana Farber Cancer Institute. Archived from the original on 2015-04-07.
  4. ^ "Computational Biology and Functional Genomics Laboratory - John Quackenbush". Harvard University. Archived from the original on 2015-01-25.
  5. ^ "John Quackenbush, Harvard School of Public Health Bio". Harvard University. Archived from the original on 2011-02-25.
  6. PMID 19202193
    .
  7. PMID 12466851
    .
  8. PMID 19377474
    .
  9. S2CID 8712839
    .
  10. ^ a b c d e f Staff (2014). "2014-BIT-Brochure" (PDF). 2014 Bio-IT World Expo. Cambridge Healthtech Institute. p. 4. Retrieved 15 June 2016.
  11. OCLC 22713736 – via ProQuest
    .
  12. ^ Dublin, Matthew (31 May 2009). "Dana-Farber, Quackenbush Launch Analysis Consultancy Center | Genome Technology | Informatics". GenomeWeb. Retrieved 2012-05-07.
  13. ^ "Integrating Clinical and Genomics Data". Bio-IT World. Retrieved 2012-05-07.
  14. ^ "John Quackenbush, Lung Genomics Research Consortium Investigator Bio". lung-genomics.org. Archived from the original on 2012-03-19.
  15. ^ "Lung Genomics Research Consortium Launches Website". National Jewish Organization. Retrieved 2013-04-04.
  16. ^ "Industry-News.net - Home". Biotechnologynews.net. Retrieved 2012-05-07.
  17. ISBN 978-0-309-10413-5
    . Retrieved 2013-04-04.
  18. ISBN 978-0-309-10413-5
    . Retrieved 2013-04-04.
  19. PMID 21210553
    . Retrieved 2013-04-04.
  20. ISBN 978-0-309-22418-5
    . Retrieved 2013-04-04.
  21. ^ Celebrating “Open Science” Champions of Change at the White House
Retrieved from "https://en.wikipedia.org/w/index.php?title=John_Quackenbush&oldid=1193093736"